Ocular Imaging Study Using Advanced OCT

University of California, Los Angeles (UCLA)

Status: Unknown

Conditions: Retinal Vascular Disorder; Macular Degeneration

Study type: Observational

Funder types: Other

Identifiers

NCT02827071

JSEI Nidek Advanced OCT

Details and patient eligibility

About

The purpose of this study is to evaluate this AngioScan angiography software on patients with various retinal vascular disorders. The advanced OCT instrument is an FDA approved clinically used camera, but the AngioScan angiography software is not FDA approved. Investigators would like to know if this imaging device and software can improve the quality of images and visualization of imaged tissues and whether they are useful in the diagnosis and treatment of eye diseases. Images collected in this study may be compared to other images collected as part of standard of care on the same patient (OCT, FA, AF, Fundus).

Enrollment: 1,000 estimated patients

Sex: All

Ages: 18 to 115 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Any patient with abnormal retinal findings as determined by investigators.

Exclusion criteria

• Those suffering from head, neck or other injury which makes them unable to position themselves in head restraint for imaging.
• Participants who are unable to maintain retinal fixation on a specified target.
• Participants unable to achieve sufficient pupil dilation and alignment stability for imaging to take place.
• Patients with media opacity which preclude high quality imaging.

Trial design

1,000 participants in 1 patient group

Retina abnormalities

Description:

Subjects with various retina vascular disorders